These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 2443619

  • 41. Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
    Kosmidis PA, Tsavaris N, Skarlos D, Theocharis D, Samantas E, Pavlidis N, Briassoulis E, Fountzilas G.
    J Clin Oncol; 1996 Oct; 14(10):2682-7. PubMed ID: 8874327
    [Abstract] [Full Text] [Related]

  • 42. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.
    Budd GT, Fleming TR, Bukowski RM, McCracken JD, Rivkin SE, O'Bryan RM, Balcerzak SP, Macdonald JS.
    J Clin Oncol; 1987 Feb; 5(2):272-7. PubMed ID: 3543246
    [Abstract] [Full Text] [Related]

  • 43. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
    Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG.
    J Clin Oncol; 1989 Apr; 7(4):425-32. PubMed ID: 2926468
    [Abstract] [Full Text] [Related]

  • 44. Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
    André T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Billiau V, Buyse M, Gramont A, Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):35-40. PubMed ID: 11273588
    [Abstract] [Full Text] [Related]

  • 45. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 46. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW, Choi IK, Seo JH, Kim BS, Kim JS, Kim CD, Um SH, Kim JS, Kim YH.
    Am J Clin Oncol; 2000 Aug 15; 23(4):425-8. PubMed ID: 10955877
    [Abstract] [Full Text] [Related]

  • 47. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Dorta J, Blanco E, Fernández-Martos C, Cruz-Hernandez JJ, Carrato A, Gonzalez-Mancha R, García-Conde J, Díaz-Rubio E.
    Cancer; 1995 Aug 15; 76(4):559-63. PubMed ID: 8625147
    [Abstract] [Full Text] [Related]

  • 48. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK.
    J Clin Oncol; 1992 Aug 15; 10(8):1245-51. PubMed ID: 1634913
    [Abstract] [Full Text] [Related]

  • 49. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C, Louvet C, de Gramont A, Lucchi E, Seitz JF, Mal F, Raymond E, Cady J, Carola E, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1094-9. PubMed ID: 9070485
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB.
    J Clin Oncol; 2001 May 01; 19(9):2413-21. PubMed ID: 11331320
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
    Hasegawa S, Akaike M, Yamamoto Y, Shiraishi R, Ozawa Y, Suzuki H, Miyazaki T, Kasahara A, Makino T, Tamura I, Tanabe H, Rino Y.
    Gan To Kagaku Ryoho; 2004 May 01; 31(5):729-33. PubMed ID: 15170981
    [Abstract] [Full Text] [Related]

  • 57. The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.
    Marsh JC, Bertino JR, Katz KH, Davis CA, Durivage HJ, Rome LS, Richards F, Capizzi RL, Farber LR, Pasquale DN.
    J Clin Oncol; 1991 Mar 01; 9(3):371-80. PubMed ID: 1999706
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M, Jaehde U, Stremetzne S, Ridwelski K, Kerz H, Strohbach F, Hohenberger P, Zwiebel FM, Hebart H, Böthig R, Kairies M, Zillig D, Schuchmann S, Warnecke S, Thiel E, Kreuser ED.
    Ann Oncol; 1997 Nov 01; 8(11):163-5. PubMed ID: 9426339
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.